Search research articles
Contact Us
Filters
Showing results (1-10 of 113) with videos related to
Page
of 12
Sort By:
Clinical Advances in Hematology & Oncology : H&O
|
June 20, 2009
Clinical roundtable monograph: safety and efficacy of lipid-based amphotericin B
Romuald Bellmann, John D Cleary, Jaroslav Sterba
Cancer Cell International
|
March 2, 2016
Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation
Martin Sramek, Jakub Neradil, Jaroslav Sterba, et al.
Journal of Molecular Histology
|
August 31, 2010
Analysis of the intracellular localization of p73 N-terminal protein isoforms TAp73 and ∆Np73 in medulloblastoma cell lines
Marta Nekulová, Karel Zitterbart, Jaroslav Sterba, et al.
Current Cancer Drug Targets
|
August 20, 2010
Anti-angiogenic therapies for children with cancer
Nicolas André, Arnauld Verschuur, Jochen Rossler, et al.
Clinical Chemistry
|
February 4, 2006
Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited
Jaroslav Sterba, Ladislav Dusek, Regina Demlova, et al.
International Journal of Molecular Sciences
|
September 12, 2020
Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All-<i>Trans</i> Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor α Expression in Osteosarcoma Cell Lines
Silvia Paukovcekova, Dalibor Valik, Jaroslav Sterba, et al.
Pharmacogenomics
|
December 9, 2004
Homocysteine: exploring its potential as a pharmacodynamic biomarker of antifolate chemotherapy
Dalibor Valik, Martin Radina, Jaroslav Sterba, et al.
Oncology
|
September 17, 2005
Severe encephalopathy induced by the first but not the second course of high-dose methotrexate mirrored by plasma homocysteine elevations and preceded by extreme differences in pretreatment plasma folate
Dalibor Valik, Jaroslav Sterba, Viera Bajciova, et al.
Future Oncology (London, England)
|
January 29, 2026
Molecular preselection of pediatric patients with solid tumors treated with tyrosine kinase inhibitors
Peter Sisovsky, Nikola Gejgusova, Tomas Fazekas, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
July 22, 2009
Treatment of deep venous thrombosis with low molecular weight heparin in pediatric cancer patients: safety and efficacy
Katerina Tousovska, Ondrej Zapletal, Jarmila Skotakova, et al.
Page
of 12
Search research articles
Search
Showing results (1-10 of 113) with videos related to
Sort By:
Page
of 12
Clinical Advances in Hematology & Oncology : H&O
|
June 20, 2009
Clinical roundtable monograph: safety and efficacy of lipid-based amphotericin B
Romuald Bellmann, John D Cleary, Jaroslav Sterba
Cancer Cell International
|
March 2, 2016
Non-DHFR-mediated effects of methotrexate in osteosarcoma cell lines: epigenetic alterations and enhanced cell differentiation
Martin Sramek, Jakub Neradil, Jaroslav Sterba, et al.
Journal of Molecular Histology
|
August 31, 2010
Analysis of the intracellular localization of p73 N-terminal protein isoforms TAp73 and ∆Np73 in medulloblastoma cell lines
Marta Nekulová, Karel Zitterbart, Jaroslav Sterba, et al.
Current Cancer Drug Targets
|
August 20, 2010
Anti-angiogenic therapies for children with cancer
Nicolas André, Arnauld Verschuur, Jochen Rossler, et al.
Clinical Chemistry
|
February 4, 2006
Pretreatment plasma folate modulates the pharmacodynamic effect of high-dose methotrexate in children with acute lymphoblastic leukemia and non-Hodgkin lymphoma: "folate overrescue" concept revisited
Jaroslav Sterba, Ladislav Dusek, Regina Demlova, et al.
International Journal of Molecular Sciences
|
September 12, 2020
Enhanced Antiproliferative Effect of Combined Treatment with Calcitriol and All-<i>Trans</i> Retinoic Acid in Relation to Vitamin D Receptor and Retinoic Acid Receptor α Expression in Osteosarcoma Cell Lines
Silvia Paukovcekova, Dalibor Valik, Jaroslav Sterba, et al.
Pharmacogenomics
|
December 9, 2004
Homocysteine: exploring its potential as a pharmacodynamic biomarker of antifolate chemotherapy
Dalibor Valik, Martin Radina, Jaroslav Sterba, et al.
Oncology
|
September 17, 2005
Severe encephalopathy induced by the first but not the second course of high-dose methotrexate mirrored by plasma homocysteine elevations and preceded by extreme differences in pretreatment plasma folate
Dalibor Valik, Jaroslav Sterba, Viera Bajciova, et al.
Future Oncology (London, England)
|
January 29, 2026
Molecular preselection of pediatric patients with solid tumors treated with tyrosine kinase inhibitors
Peter Sisovsky, Nikola Gejgusova, Tomas Fazekas, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis
|
July 22, 2009
Treatment of deep venous thrombosis with low molecular weight heparin in pediatric cancer patients: safety and efficacy
Katerina Tousovska, Ondrej Zapletal, Jarmila Skotakova, et al.
Page
of 12